Anatomic Stage IIIA Breast Cancer AJCC v8 Completed Phase Trials for Regadenoson (DB06213)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03505736Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer